Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05020925
What this trial is testing

SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT02871518
What this trial is testing

Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 236
Large-scale testing (Phase 3)UnknownNCT00181038
What this trial is testing

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Who this might be right for
Oropharyngeal Neoplasms
Gustave Roussy, Cancer Campus, Grand Paris 40
Testing effectiveness (Phase 2)UnknownNCT02187315
What this trial is testing

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

Who this might be right for
Nasopharyngeal Carcinoma
Feng Jing 160
Early research (Phase 1)Study completedNCT01140178
What this trial is testing

A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx

Who this might be right for
DysplasiaCarcinoma of the Oral CavityCarcinoma of the Oropharynx
Roswell Park Cancer Institute 29
Not applicableStudy completedNCT01342978
What this trial is testing

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time

Who this might be right for
Oropharyngeal CancerHuman Papillomavirus
Johns Hopkins Bloomberg School of Public Health 242
Testing effectiveness (Phase 2)Looking for participantsNCT07762976
What this trial is testing

Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Fudan University 148
Early research (Phase 1)Study completedNCT04215978
What this trial is testing

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma (HNSCC)+1 more
BeiGene 204
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)UnknownNCT03904225
What this trial is testing

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 220
Large-scale testing (Phase 3)Not Yet RecruitingNCT06095167
What this trial is testing

Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 476
Testing effectiveness (Phase 2)WithdrawnNCT03390738
What this trial is testing

Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
The University of Hong Kong
Not applicableUnknownNCT06170021
What this trial is testing

Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 215
Testing effectiveness (Phase 2)UnknownNCT05232552
What this trial is testing

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 37
Not applicableUnknownNCT01182909
What this trial is testing

Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Far Eastern Memorial Hospital 4,000
Not applicableStudy completedNCT05696314
What this trial is testing

Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx

Who this might be right for
Oropharynx CancerTonsil CancerBase of the Tongue Tumor+5 more
Rigshospitalet, Denmark 201
Testing effectiveness (Phase 2)Study completedNCT04834206
What this trial is testing

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07332247
What this trial is testing

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

Who this might be right for
Nasopharangeal CancerRecurrent Nasopharynx Carcinoma
Sun Yat-sen University 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT05172258
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+12 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06733948
What this trial is testing

ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 50
Next Page
52